Zacks.com releases the latest Analyst Interview. Today’s
interview is with senior analyst Christopher Titus, who discusses Hanger
Orthopedics (NYSE: HGR) and ArthroCare (Nasdaq: ARTC).
Get the most recent insight from Zacks Equity Research with the free
Profit from the Pros newsletter: http://at.zacks.com/?id=2678.
Which stocks are your top Buy recommendations at this time?
The orthopedics group. At this point, Hanger Orthopedics (NYSE:
HGR) is our only Buy-rated stock in that group. ArthroCare
(Nasdaq: ARTC), a manufacturer of coblation technology, is our other
Buy-rated stock. However, ARTC has reached our target price, rising 21%
since our last report.
Is there anything the average investor should know about pursuing
medical devices stocks that they may not know?
As with all stocks, investors need to be conscious of the risks
involved. The medical device industry in the aggregate has produced
fairly consistent results for some time now.
However, on an individual basis, many names are quite volatile.
Investors shouldn't lose sight of the continual innovation and
infrastructure required to support such innovation.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative
analysis to help investors know what stocks to buy and which to sell for
the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded
stocks. Our analysts are organized by industry which gives them keen
insights to developments that affect company profits and stock
performance. Recommendations and target prices are six-month time
horizons.
Zacks Profit from the Pros e-mail newsletter provides highlights of the
latest analysis from Zacks Equity Research. Subscribe to this free
newsletter today by visiting http://at.zacks.com/?id=2679.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was
formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he
could find patterns in stock market data that would lead to superior
investment results. Amongst his many accomplishments was the formation
of his proprietary stock picking system; the Zacks Rank, which continues
to outperform the market by nearly a 3 to 1 margin. The best way to
unlock the profitable stock recommendations and market insights of Zacks
Investment Research is through our free daily email newsletter; Profit
from the Pros. In short, it's your steady flow of Profitable ideas
GUARANTEED to be worth your time! Register for your free subscription to
Profit from the Pros at http://at.zacks.com/?id=4581.
Visit http://www.zacks.com/performance
for information about the performance numbers displayed in this press
release.
Disclaimer: Past performance does not guarantee future results.
Investors should always research companies and securities before making
any investments. Nothing herein should be construed as an offer or
solicitation to buy or sell any security.
